Supplement Company Warned on Unapproved Ingredients, GMPs

Drug Industry Daily
A A
Three unapproved ingredients and a host of labeling and other GMP violations have resulted in an FDA warning letter for a Texas-based supplement company.

To View This Article:

Login

Subscribe To Drug Industry Daily